InMode Ltd (INMD) is a Healthcare · Medical Devices company listed on NASDAQ. Price $14.35 (-1.31%), Market cap $0.85B, P/E ratio 10.31, 52-week low–high $12.76 ~ $16.62.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including perman
Financial statements, price targets, institutional (13F) holdings and related news for InMode Ltd are updated in real time on BlackAll Trade.
InMode Ltd trades at $14.35 (-1.31%). Real-time quotes and charts are available on BlackAll Trade.
InMode Ltd has a market cap of about $0.85B. Its P/E ratio is 10.31.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofr